Table of Contents - Espicom

More documents

Recommendations

Info

Table of Contents xiv © Espicom Business Intelligence © 2012 UBM Semiconductor Insights Diabetes Landscape: Figure 5.90 - Continuous Implanted by Published Date............................................................................................................................................................................. 370 IPC Analysis – Top 10 Codes: ............................................................................................................................................................... 371 Figure 5.91 - Continuous Implanted by IPC Code ....................................................................................................................................................................................... 371 USPC Analysis – Top 10 Codes: ........................................................................................................................................................... 372 Figure 5.92 - Continuous Implanted by USPC Code .................................................................................................................................................................................... 372 Text Clustering Analysis: ..................................................................................................................................................................... 373 Figure 5.93 – Continuous Implanted - Text Clustering Analysis ................................................................................................................................................................ 373 Source Jurisdiction: ...............................................................................................................................................................................374 Figure 5.94 - Continuous Implanted by Source Jurisdiction ....................................................................................................................................................................... 374 Top Patents ............................................................................................................................................................................................ 375 Table 5.9 - Top Patents Identified in the Continuous Implanted Group ..................................................................................................................................................... 375 Figure 5.95 – Representative Image in US6001067 ................................................................................................................................................................................... 376 Figure 5.96 – Top 20 Companies Citing US6001067 .................................................................................................................................................................................. 377 5.10 Treatment – Manual – Syringe ........................................................................................................................................ 378 Figure 5.97 – Syringe – Top Assignees....................................................................................................................................................................................................... 378 Priority Date by Year: ........................................................................................................................................................................... 379 Figure 5.98 - Syringe by Priority Date ......................................................................................................................................................................................................... 379 Priority Date by Year by Assignee: .................................................................................................................................................... 379 Figure 5.99 - Syringe by Priority Date by Assignee ..................................................................................................................................................................................... 379 Published Date by Year: ...................................................................................................................................................................... 380 Figure 5.100 - Syringe by Published Date ...................................................................................................................................................................................................380 IPC Analysis – Top 10 Codes: ............................................................................................................................................................... 381 Figure 5.101 - Syringe by IPC Code .............................................................................................................................................................................................................. 381 USPC Analysis – Top 10 Codes: ........................................................................................................................................................... 382 Figure 5.102 - Syringe by USPC Code ..........................................................................................................................................................................................................382 Text Clustering Analysis: ..................................................................................................................................................................... 383 Figure 5.103 – Syringe - Text Clustering Analysis .......................................................................................................................................................................................383 Source Jurisdiction: .............................................................................................................................................................................. 384 Figure 5.104 - Syringe by Source Jurisdiction .............................................................................................................................................................................................384 Top Patents ............................................................................................................................................................................................ 384 Table 5.10 - Top Patents Identified in the Syringe Group ............................................................................................................................................................................384 US6254586: Medtronic, Inc. ............................................................................................................................................ 385 Figure 5.105 – Representative Image in US6254586 .................................................................................................................................................................................385 Figure 5.106 – Top 20 Companies Citing US6254586 ................................................................................................................................................................................386 5.11 Treatment – Manual – Pen................................................................................................................................................387 Figure 5.107 – Pen – Top Assignees ........................................................................................................................................................................................................... 387 Priority Date by Year: ........................................................................................................................................................................... 388 Figure 5.108 - Pen by Priority Date .............................................................................................................................................................................................................388 Priority Date by Year by Assignee: .................................................................................................................................................... 388 Figure 5.109 - Pen by Priority Date by Assignee .........................................................................................................................................................................................388 Published Date by Year: ...................................................................................................................................................................... 389 Figure 5.110 - Pen by Published Date .........................................................................................................................................................................................................389 IPC Analysis – Top 10 Codes: ............................................................................................................................................................... 390 Figure 5.111 - Pen by IPC Code ....................................................................................................................................................................................................................390 USPC Analysis – Top 10 Codes: ........................................................................................................................................................... 391 Figure 5.112 - Pen by USPC Code ................................................................................................................................................................................................................. 391 Text Clustering Analysis: ..................................................................................................................................................................... 392 Figure 5.113 – Pen - Text Clustering Analysis ............................................................................................................................................................................................. 392 Source Jurisdiction: .............................................................................................................................................................................. 393 Figure 5.114 - Pen by Source Jurisdiction .................................................................................................................................................................................................... 393 Top Patents ............................................................................................................................................................................................ 394 Table 5.11 - Top Patents Identified in the Pen Group ..................................................................................................................................................................................394 US6192891: Becton, Dickinson and Company ................................................................................................................395 Figure 5.115 – Representative Image in US6192891 .................................................................................................................................................................................. 395 Figure 5.116 – Top 20 Companies Citing US6192891 .................................................................................................................................................................................396 May 2012
Diabetes Landscape: May 2012 © Espicom Business Intelligence © 2012 UBM Semiconductor Insights Table of Contents US5514097: Roche Holding Ltd. .......................................................................................................................................397 Figure 5.117 – Representative Image in US5514097 .................................................................................................................................................................................. 397 Figure 5.118 – Top 20 Companies Citing US5514097 .................................................................................................................................................................................398 5.12 Treatment – Manual - Patch .............................................................................................................................................399 Figure 5.119 – Patch – Top Assignees ........................................................................................................................................................................................................399 Priority Date by Year: ...........................................................................................................................................................................400 Figure 5.120 - Patch by Priority Date ..........................................................................................................................................................................................................400 Priority Date by Year by Assignee: ....................................................................................................................................................400 Figure 5.121 - Patch by Priority Date by Assignee ......................................................................................................................................................................................400 Published Date by Year: ...................................................................................................................................................................... 401 Figure 5.122 - Patch by Published Date ......................................................................................................................................................................................................401 IPC Analysis– Top 10 Codes: .............................................................................................................................................. 402 Figure 5.123 - Patch by IPC Code .................................................................................................................................................................................................................402 USPC Analysis – Top 10 Codes: ........................................................................................................................................................... 403 Figure 5.124 - Patch by USPC Code ..............................................................................................................................................................................................................403 Text Clustering Analysis: .....................................................................................................................................................................404 Figure 5.125 – Patch - Text Clustering Analysis ..........................................................................................................................................................................................404 Source Jurisdiction: .............................................................................................................................................................................. 405 Figure 5.126 - Patch by Source Jurisdiction ................................................................................................................................................................................................405 Top Patents ............................................................................................................................................................................................ 405 Table 5.12 - Top Patents Identified in the Patch Group ...............................................................................................................................................................................405 US6682757: Purdue Pharma LP ....................................................................................................................................... 406 Figure 5.127 – Representative Image in US6682757 .................................................................................................................................................................................406 Figure 5.128 – Top 20 Companies Citing US6682757 .................................................................................................................................................................................407 5.13 Treatment – Manual – Other ...........................................................................................................................................408 Figure 5.129 – Treatment - Other – Top Assignees ....................................................................................................................................................................................408 Priority Date by Year: ...........................................................................................................................................................................409 Figure 5.130 – Treatment – Other by Priority Date ...................................................................................................................................................................................409 Priority Date by Year by Assignee: ....................................................................................................................................................409 Figure 5.131 – Treatment – Other by Priority Date by Assignee ................................................................................................................................................................409 Published Date by Year: .......................................................................................................................................................................410 Figure 5.132 - Treatment – Other by Published Date ................................................................................................................................................................................. 410 IPC Analysis – Top 10 Codes: ................................................................................................................................................................411 Figure 5.133 – Treatment – Other by IPC Code .......................................................................................................................................................................................... 411 USPC Analysis – Top 10 Codes: ............................................................................................................................................................412 Figure 5.134 – Treatment - Other by USPC Code ........................................................................................................................................................................................ 412 Text Clustering Analysis: ......................................................................................................................................................................413 Figure 5.135 – Treatment – Other - Text Clustering Analysis..................................................................................................................................................................... 413 Source Jurisdiction: ...............................................................................................................................................................................414 Figure 5.136 – Treatment - Other by Source Jurisdiction ........................................................................................................................................................................... 414 Top Patents .............................................................................................................................................................................................414 Table 5.13 - Top Patents Identified in the Treatment – Other Group ......................................................................................................................................................... 414 US6313093: Novartis AG ...................................................................................................................................................415 Figure 5.137 – Top 20 Companies Citing US6313093 ................................................................................................................................................................................. 415 5.14 Treatment – Automatic – External Pump ...................................................................................................................... 416 Figure 5.138 – External Pump – Top Assignees ......................................................................................................................................................................................... 416 Priority Date by Year: ............................................................................................................................................................................417 Figure 5.139 - External Pump by Priority Date ........................................................................................................................................................................................... 417 Priority Date by Year by Assignee: .....................................................................................................................................................417 Figure 5.140 - External Pump by Priority Date by Assignee ....................................................................................................................................................................... 417 Published Date by Year: .......................................................................................................................................................................418 Figure 5.141 - External Pump by Published Date ....................................................................................................................................................................................... 418 IPC Analysis – Top 10 Codes: ................................................................................................................................................................419 Figure 5.142 - External Pump by IPC Code .................................................................................................................................................................................................. 419 USPC Analysis – Top 10 Codes: ........................................................................................................................................................... 420 xv
Page 1 and 2: DIABETES LANDSCAPE Market, Technolo
Page 3 and 4: Diabetes Landscape: CONTENTS Table
Page 5 and 6: Diabetes Landscape: May 2012 © Esp
Page 13: Diabetes Landscape: May 2012 © Esp
Page 17 and 18: Diabetes Landscape: Table of Conten

Table of Contents - Espicom

Create successful ePaper yourself

Delete template?

Save as template?